Your browser doesn't support javascript.
loading
Safety, tolerability, pharmacokinetics and pharmacodynamics of the anti-CD38 cytolytic antibody TAK-079 in healthy subjects.
Fedyk, Eric R; Zhao, Lin; Koch, Annelize; Smithson, Glennda; Estevam, Jose; Chen, Grace; Lahu, Gezim; Roepcke, Stefan; Lin, Jianchang; Mclean, Lachy.
Afiliação
  • Fedyk ER; Takeda Pharmaceuticals International, Deerfield, IL, USA.
  • Zhao L; Takeda Pharmaceuticals International, Deerfield, IL, USA.
  • Koch A; Parexel, Harrow, UK.
  • Smithson G; Takeda Pharmaceuticals International, Deerfield, IL, USA.
  • Estevam J; Takeda Oncology, Cambridge, MA, USA.
  • Chen G; Takeda Pharmaceuticals International, Deerfield, IL, USA.
  • Lahu G; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Roepcke S; Takeda Pharmaceuticals International AG, Zurich, Switzerland.
  • Lin J; Takeda Oncology, Cambridge, MA, USA.
  • Mclean L; Takeda California, San Diego, CA, USA.
Br J Clin Pharmacol ; 86(7): 1314-1325, 2020 07.
Article em En | MEDLINE | ID: mdl-32045493
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Monoclonais / Antineoplásicos Idioma: En Ano de publicação: 2020 Tipo de documento: Article